Allero Therapeutics‘ Immunotherapy Approach in Food-Induced Immune Disorders Validated by Two Peer-Reviewed Publications

Allero Therapeutics BV, a Dutch oromucosal immunotherapy company, today announced the publication of two studies further detailing and validating its approach to combat food-induced immune disorders with its SOMIT (Specific […]

Weiterlesen

Allero Therapeutics and Abbreos join forces to clinically develop COVID-19 program

Allero Therapeutics BV, a Belgian-Dutch oromucosal immunotherapy company, and Abbreos Inc., a US- based IND-stage company focused on developing treatments that dampen hyperactive immune responses, today announced a clinical development […]

Weiterlesen